Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells

Journal of Biochemistry

Volumn 146, Issue 5, 2009, Pages 693-703

  Biswal, Bijesh Kumar ^a   Verma, Rama Shanker ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Folate receptor; Folic acid; Methotrexate; MOLT4 cells; Reduced folate carrier

Indexed keywords

ANION; FOLATE RECEPTOR; FOLATE RECEPTOR ANTIBODY; FOLIC ACID; METHOTREXATE; MITOMYCIN C; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VERAPAMIL;

ACTIVE TRANSPORT; ANION TRANSPORT; ARTICLE; CELL PH; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG TRANSPORT; DRUG UPTAKE; ENERGY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA CELL; MOLECULAR MECHANICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANTIBODIES; BIOLOGICAL TRANSPORT; BUFFERS; CARRIER PROTEINS; CELL LINE, TUMOR; FOLIC ACID; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; IONS; LEUKEMIA; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MITOMYCIN; PHOSPHATES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFASALAZINE; SULFATES; T-LYMPHOCYTES; TIME FACTORS; VERAPAMIL;

EID: 70449646674     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvp130     Document Type: Article

References (43)

1. Stockstad, E.L.R. (1990) Folic acid metabolism in health and disease. (Piccianno, M.F., Stockstad, E.L.R., and Greory, J.F., eds.), pp. 1-21, Wiley-Liss, Inc. New York
2. Davis, R.E. and Nicol, D.J. (1988) Folic acid. Int. J. Biochem. 20, 133-139
3. Choi, S.W. and Mason, J.B. (2000) Folate and carcinogenesis: an integrated scheme. J. Nutr. 130, 129-132
4. Selhub, J. (1999) Homocysteine metabolism. Ann. Rev. Nutr. 19, 217-246
5. Pietrzik, K. and Bronstrup, A. (1997) Folate in preventive medicine: a new role in cardiovascular disease, neural tube defects and cancer. Ann. Nutr. Metab. 41, 331-343
6. Moscow, J.A. (1998) Methotrexate transport and resistance. Leuk. Lymphoma. 30, 215-224
7. Sirotnak, F.M. and Tolner, B. (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19, 91-122
8. Sierra, E.E. and Goldman, I.D. (1999) Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin. Oncol. 26, 11-23
9. Antony, A.C. (1996) Folate receptors. Annu. Rev. Nutr. 16, 501-521
10. Goldman, I.D. (1971) The characteristics of the membrane transport of aminopterin and naturally occurring folates. Ann. N. Y. Acad. Sci. 186, 400-422
11. Henderson, G.B. and Zevely, E.M. (1981) Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem. Biophys. Res. Commun. 99, 163-169
12. Qiu, A., Jansen, M., Sakaris, A., Min, S.H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M.H., and Goldman, I.D. (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127, 917-928
13. Wolfe, F. and Hawley, J.D. (1998) The long term outcomes of RA: Work Disability: A Prospective 18 Year Study of 823 Patients. J. Rheumatol. 25, 2108-2117
14. Pavy, S., Constantin, A., Pham, T., Gossec, L., Maillefert, J.F., Cantagrel, A., Combe, B., Flipo, R.M., Goupille, P., Loet, X.L., Mariette, X., Puechal, X., Schaeverbeke, T., Sibilia, J., Tebib, J., Wendling, D., and Dougados, M. (2006) Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Join. Bone Spine 73, 388-395 (Pubitemid 44056248)
15. Graciela, S.A. (2000) Methotrexate use in rheumatoid arthritis. A clinician's perspective. Immunopharmacol. 47, 259-271
16. Andrea, T.B., Carl, L.K., Gurtej, S.C., and Gershwin, M.E. (2004) The use of methotrexate in rheumatoid arthritis. Semin. Arthritis Rheumat. 34, 465-483
17. Jansen, G., van der Heijden, J., Oerlemans, R., Lems, W.F., Ifergan, I., Scheper, R.J., Assaraf, Y.G., and Dijkmans, B.A. (2004) Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum. 50, 2130-2139
18. Itoh, T., Ono, K.I., Li, Y.H., and Yamada, H. (2001) Stereoselectivity of the folate transporter in rabbit small intestine: studies with amethopterin enantiomers. Chirality 13, 164-169
19. Birn, H., Spiegdstein, O., Christensen, E.I., and Finnell, R.T. (2005) Renal Tubular Reabsorption of Folate Mediated by Folate Binding Protein 1. J. Am. Soc. Nephrol. 16, 608-615
20. Verma, R.S., Gullapalli, S., and Antony, A.C. (1992) Evidence that the hydrophobicity of isolated, in situ, and de novo- synthesized native human placental folate receptors is a function of glycosyl-phosphatidylinositol anchoring to membranes. J. Biol. Chem. 267, 4119-4127
21. Nabokina, S.M., Ma, T.Y., and Said, H.M. (2004) Mechanism and regulation of folate uptake by human pancreatic epithelial MIA PaCa-2 cells. Am. J. Physiol. Cell Physiol. 287, C142-C148
22. Horne, D.W. and Reed, K.A. (2001) Transport of methotrexate into PC-3 human prostate cancer cells. Arch. Biochem. Biophys. 394, 39-44
23. Jansen, G., Westerhof, G.R., Jarmuszewski, M.J.A., Kathmann, I., Rijksen, G., and Schornagel, J.H. (1990) Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. J. Biol. Chem. 265, 18272-18277
24. Weitman, S.D., Lark, R.H., Coney, L.R., Fort, D.W., Frasca, V., Zurawski Jr, V.R., and Kamen, B.A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401
25. Reddy, J.A. and Low, P.S. (1998) Folate-mediated targeting of therapeutic and imaging agents to cancer. Crit. Rev. Ther. Drug Carrier Syst. 15, 587-627
26. Gruner, B.A. and Weitman, S.D. (1998) The folate receptor as a potential therapeutic anticancer target. Invest. New Drugs 16, 205-219
27. Chomczynski, P. and Sacchi, N. (2006) The single-step method of RNA isolation by acid guanidinium thiocyanatephenol- chloroform extraction: twenty-something years on. Nat. Prot. 1, 581-585
28. Prasad, P.D., Ramamoorthy, S., Moe, A.J., Smith, C.H., Leibach, F.H., and Ganapathy, V. (1994) Selective expression of the high-affinity isoform of the folate receptor (FR-a) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim. Biophys. Acta. 1223, 71-75
29. Said, H.M., Chatterjee, N., Haq, R.V., Subramanian, V.S., Ortiz, A., Matherly, L.H., Sirotnak, F.M., Halsted, C., and Rubin, S.A. (2000) Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. Am. J. Physiol. Cell Physiol. 279, C1889-C1895
30. Horne, D.W. and Reed, K.A. (2003) Uptake of 5-methyltetrahydrofolate into PC-3 human prostate cancer cells is carrier-mediated. J. Nutr. Biochem. 14, 473-479
31. Said, H.M., Ghishan, F.K., and Redha, R. (1987) Folate transport by human intestinal brush-border membrane vesicles. Am. J. Physiol. 252, G229-G236
32. + and pH dependence of 5-methyltetrahydrofolic acid and methotrexate transport in freshly isolated hepatocytes. Biochem. Biophys. Acta. 1023, 47-55
33. Sierra, E.E., Brigle, K.E., Spinella, M.J., and Goldman, I.D. (1995) Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells. Biochem. Pharmacol. 50, 1287-1294
34. Sierra, E.E., Brigle, K.E., Spinella, M.J., and Goldman, I.D. (1995) Distinguishing between folate receptor a-mediated transport and reduced folate carrier- mediated transport in L1210 leukemia cells. J. Biol. Chem. 270, 7842-7849
35. Nakai, Y., Inoue, K., Abe, N., Hatakeyama, M., Ohta, K., Otagiri, M., Hayashi, Y., and Yuasa, H. (2007) Functional characterization of human proton-coupled folate transporter/ heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J. Pharmacol. Exp. Ther. 322, 469-476
36. Zhao, R. and Goldman, I.D. (2007) The molecular identity and characterization of a proton-coupled folate transporter- PCFT; biological ramifications and impact on the activity of pemetrexed. Cancer Metasta. Rev. 26, 129-139
37. Goldman, I.D. (1971) The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann. N. Y. Acad. Sci. 186, 400-422
38. Henderson, G.B. and Zevely, E.M. (1980) Transport of methotrexate in L1210 cells: Effect of ions on the rate and extent of uptake. Arch. Biochem. Biophys. 200, 149-155
39. Yang, C.H., Sirotnak, F.M., and Dembo, M. (1984) Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: Directional symmetry and anion specificity for differential moility of loaded and unloaded carrier. J. Membr. Biol. 79, 285-292
40. Sharina, I.G., Zhao, R., Wang, Y., Babani, S., and Goldman, I.D. (2001) Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier. Mol. Pharmacol. 59, 1022-1028
41. Horne, D.W., Briggs, W.T., and Wagner, C. (1978) Transport of 5-methyltetrahydrofolic acid and folic acid in freshly isolated hepatocytes. J. Biol. Chem. 253, 3529-3535 (Pubitemid 8349809)
42. Goldman, I.D. (1969) Transport energetics of the folic acid analogue, methotrexate, in L1210 leukemia cells. Enhanced accumulation by metabolic inhibitors. J. Biol. Chem. 244, 3779-3785
43. Schlemmer, S.R. and Sirotnak, F.M. (1992) Energydependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with insideout plasma membrane vesicles. J. Biol. Chem. 267, 14746-14752